Neuralink, the neurotechnology company co-founded by Tesla ( NASDAQ: TSLA) CEO Elon Musk, has joined a clinical trial aimed ...

To start off, Conagra's fiscal year Q4 results, released earlier this month, were a disappointment. Though Conagra's recent ...

A 15% U.S.-Japan trade deal and reports of a similar U.S.-EU deal have fueled a market resurgence. Seize the moment with 3 ...

Cal-Maine Foods thrives with zero debt and diversification efforts. Discover its long-term potential despite egg price ...

Three patient deaths linked to gene therapies developed by Sarepta Therapeutics (SRPT) have drawn FDA scrutiny on the viral ...

Equinor offers a strong value opportunity with low EV/EBITDA, resilient cash flow, and dividend growth. Click to read more on ...

In two years, BrightSpire Capital (BRSP) will be growing its dividend and seeing strong performance. Read the full analysis ...

The decline echoes a similar pattern in Q2 2022, which saw the Tech Demand Indicator score drop 12% following the first in a ...

Venu Holding faces worsening losses and a complex capital structure that clouds shareholder value despite growth plans. Learn ...

Citi's strategy overhaul under Jane Fraser focuses on capital efficiency, buybacks, and value growth. Click to read more on ...

Whitecap's merger with Veren boosts Q2 results, offering strong cash flow and synergy savings. Click to read more on why I ...

Solesence shows strong growth and profitability with solid management alignment, but valuation reflects aggressive ...